Add BrightSurf on Google Email

Novel discovery by Einstein scientists could lead to much-needed kidney failure treatment

Researchers at Albert Einstein College of Medicine found that aberrant Notch signaling plays a role in diabetic nephropathy and focal segmental glomerulosclerosis, two major causes of end-stage renal disease. They discovered that gamma secretase inhibitors can protect against kidney disease, sparking hope for new treatment options.

SourceAlbert Einstein College of Medicine·JournalNature Medicine·DateMar 12, 2008

Same-day coronary angiography and surgery safe for many patients

Researchers at Mayo Clinic have successfully developed a protocol for performing coronary angiography on the same day as elective valve surgery, reducing the need for separate hospital visits and improving patient outcomes. The study, which evaluated 226 consecutive patients, showed that 28.3% had severe coronary artery disease requiri...

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateMay 23, 2007

Call for removal of Crestor

Rosuvastatin, marketed as Crestor, has been linked to a higher incidence of rhabdomyolysis and renal insufficiency compared to other statins. The drug's manufacturer, AstraZeneca, is estimated to be seeking $20 billion in annual sales, making it morally unjustifiable to keep the drug on the market.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 24, 2004

Fish-oil supplement slows progression of kidney disease

A daily dose of fish oil significantly improves kidney function and reduces the risk of advanced kidney failure in people with IgA nephropathy. Researchers followed 106 study participants for over six years, finding sustained benefits from fish oil supplementation.

SourceMayo Clinic·JournalJournal of the American Society of Nephrology·DateSep 3, 1999